# The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study

> **NCT01725490** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 34 (actual)

## Conditions studied

- Familial Adenomatous Polyposis

## Interventions

- **DRUG:** Metformin
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01725490
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-15
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-08-30
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01725490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01725490, "The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01725490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*